APTOSE BIOSCIENCES INC (APTO)

CA03835T3091 - Common Stock

1.22  +0.06 (+5.17%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
52.36M42.60M65.45M55.77M26.86M
Research and Development
36.73M28.05M45.97M29.27M16.84M
Selling, General, and Administrative Expenses
15.54M14.43M19.32M26.35M10.02M
Operating Income
-52.36M-42.60M-65.45M-55.77M-26.86M
Interest Income/Expense
1.15M780.00K90.00K530.00K580.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-51.21M-41.82M-65.35M-55.24M-26.28M
Net Income
-51.21M-41.82M-65.35M-55.24M-26.28M
EBITDA
-52.27M-42.48M-65.30M-55.62M-26.25M
 
Per Share Data
EPS Diluted Total Ops
-7.58-6.80-11.00-10.12-7.86
Non GAAP EPS
-7.72-6.75-0.73-0.67-0.52
 
Statistics

All data in USD

Charts